MRVI - Maravai gains amid report of $17 a share takeover bid from Thomas H. Lee
2023-05-31 14:20:15 ET
- Maravai LifeSciences ( NASDAQ: MRVI ) rose 1.2% amid a report that private equity firm Thomas H. Lee bid $17 a share for the vaccine reagent vendor.
- Thomas H. Lee made the all-cash offer and is now conducting due diligence, according to a Street Insider report , which cited an unidentified source. The two sides are in talks and are said to be working with advisers on a possible deal. An unnamed strategic buyer is also said to be looking at Maravai ( MRVI ).
- The report appears to contradict a Reuters report from two weeks ago that Maravai ( MRVI ) r ejected the takeover interest from the PE firm. The report came after Betaville said Maravai ( MRVI ) had drawn takeover interest .
- The latest items come after Reuters reported last February that German lab supplies vendor Sartorius ( OTCPK:SARTF ) made a $42 per share offer for the U.S.-based life sciences company.
For further details see:
Maravai gains amid report of $17 a share takeover bid from Thomas H. Lee